Pippa (@pippaKT) header
Pippa (@pippaKT) profile picture

Renal ST5 🏴󠁧󠁢󠁳󠁣󠁴󠁿 Clinical Research Fellow with UoD & AZ 💉Frailty/Multimorbidity/Supportive Care/ Health Inequalities in Renal Disease 🫘 she/her

Joined November 2012
Photo by Pippa (@pippaKT)Photo by Pippa (@pippaKT)Photo by Pippa (@pippaKT)Photo by Pippa (@pippaKT)Photo by Pippa (@pippaKT)Photo by Pippa (@pippaKT)Photo by Pippa (@pippaKT)Photo by Pippa (@pippaKT)Photo by Pippa (@pippaKT)Photo by Pippa (@pippaKT)
My day is now exponentially better having seen this picture that someone on Facebook posted of their hamster having an abdo ultrasound 🐹
3
21
Pippa retweeted
Efficacy and safety of balcinrenone and dapagliflozin for CKD: design and baseline characteristics of the MIRO-CKD trial doi.org/10.1093/ndt/gfaf119
1
14
43
4,578
Frailty in Kidney Disease: A Comprehensive Review to Advance Its Clinical and Research Applications buff.ly/4cDuQXT (FREE) @devimol @DocForGrandma @Rasheeda_HallMD @VUMCKidney @DukeKidney
23
49
5,109
Pippa retweeted
Today is #IgANAwarenessDay! KDIGO is joining clinicians, patients, and researchers worldwide in raising awareness of IgA Nephropathy (#IgAN). Check out KDIGO IgAN resources below, and stay tuned for the KDIGO 2025 IgAN Guideline--coming this fall! Key Messages in IgAN: kdigo.co/KDIGO-IgAN-Experts-… KDIGO IgAN Guideline Work Group Members highlight evolving therapies, updated diagnostic strategies, and challenges in managing special populations, offering a preview of what’s to come in the KDIGO 2025 IgAN Guideline. Updates in IgAN: kdigo.co/Updates-in-IgAN-Vid… KDIGO IgAN Guideline Co-Chairs Brad Rovin and Jürgen Floege discuss emerging research, new therapies, and practical strategies to improve care. KDIGO IgAN Infographic: kdigo.co/2024-IgAN-Infograph… Get a quick overview of key recommendations from the upcoming KDIGO IgAN Guideline with this easy-to-follow infographic.
60
1
156
12,629
Green nephrology, or sustainable nephrology, is gaining interest due to its environmental impact, but there is a lack of original research and data available, requiring further education and research, according to a Review in #ASNCJASN. 10.2215/CJN.0000000731
9
19
2,113
🫘🎯Approach to hemodialysis catheter related blood stream infection @AJKDonline core curriculum ajkd.org/article/S0272-6386(…
1
51
173
14,545
🎉Distinguished nephrologist @DavidCWheeler2 has been awarded the prestigious O’Donoghue Lecture!🌟 His pioneering CKD research places him in the top 1% of global researchers by citation. Prof Wheeler will deliver the lecture at #UKKW25 Read more: ukkidney.org/about-us/news/p…
1
3
2
11
2,217
🫘✅Sparsentan in IgA Nephropathy Dual Endothelin Angiotension Receptor antagonist 🔥🔥PROTECT trial @ISNkidneycare
19
87
5,120
Cirrhosis & Kidney: A Dangerous Duo AKI→ AKD→ CKD isn’t just renal; it’s hepatic too Up to 50% with cirrhosis develop AKI & upto 25% may progress to CKD Spot it early, act fast #NephTwitter #Nephrology #Hepatology #MedEd #Cirrhosis #AKI #CKD 🔗dx.doi.org/10.5527/wjn.v14.i… 🆕 🆓
59
2
148
8,742
🫘Causes of AKI in Hypercalcemia ✅Direct renal vasoconstriction ✅Defect in urine concentration due to downregulation of aquaporin-polyuria-pre renal AKI ✅Hypercalcemia induced vomiting-Pre renal AKI @ISNkidneycare
58
1
223
11,005
👍New Lupus Nephritis guidelines #ACR2024 🤘Major change-Triple therapy for induction ✅
1
147
1
443
33,593
Pippa retweeted
Persistent itch in dialysis patients is more than a nuisance—it’s a serious symptom that affects quality of life, sleep, and mental health. Two free, on-demand CME webinars explore how to better recognize and manage chronic kidney disease–associated pruritus (#CKDaP) in clinical practice. Current Experiences in Identifying and Treating Itch in Patients on Hemodialysis Dr. James Burton and Dr. Carol Pollock share real-world cases and practical strategies for identifying and treating CKD-aP in patients receiving hemodialysis. Learn more: kdigo.co/Identifying-and-Tre… Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment Dr. Jörg Latus highlights the burden of CKD-aP on sleep and mental health and the role of shared decision-making in improving patient outcomes. Learn more: kdigo.co/Optimizing-CKD-aP-T… #itch #dialysis #pruritus
16
1
48
4,029
🔥Approach to Autosomal dominant tubulointerstitial kidney disease (ADTKD) @NDTsocial @hjanders_hans academic.oup.com/ndt/article…
20
65
4,621
Now online in @NDTsocial The evolving spectrum of kidney amyloidosis 🧐 Advances in diagnosis, typing and treatment ▶️academic.oup.com/ndt/article…
47
111
5,910
Antiphospholipid Syndrome (APS): The Silent Thrombophilia From molecular pathogenesis to devastating thrombotic complications—#APS is a ticking time bomb! ⏳🧬 📖 APS review: doi.org/10.3390/jcm14030733 (2025) #Nephrology #Thrombosis #Lupus #MedTwitter #Rheumatology #Autoimmune
3
63
195
9,860
✌️Cirrhosis and Ascites By @TinaPhamHang
100
365
36,618
Recognize and Mitigate the Contrast Associated AKI @goKDIGO @NephJC infographic by @JasmineNephro
43
119
14,485
🧬 This #AKI diagnostic flowchart is a game-changer—uncover glomerulonephritis🫘, rhabdomyolysis, & more with targeted tests. Must-know for every nephrologist! 🔍 📖doi.org/10.1186/s13054-016-1… #Nephrology #MedEd #CriticalCare #NephX
1
68
193
14,598
🎯🫘Novel oral anticoagulant dosing in CKD @AJKDonline ajkd.org/article/S0272-6386(…
37
1
135
10,564
Pippa retweeted
Upcoming drug targets for kidney protective effects in chronic kidney disease 🆓doi.org/10.1093/ndt/gfae216
53
114
6,031
✅Revised criteria for diagnosis of Antiphospholipid syndrome APS @KIReports kireports.org/action/showPdf…
1
121
2
421
36,533